Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
27.08+0.48 (+1.80%)
At close: 04:00PM EST
27.33 +0.25 (+0.92%)
After hours: 04:40PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
307,380
618,968
992,584
421,712
32,528
Cost of revenue
208,915
252,067
215,533
89,807
14,107
Gross profit
98,465
366,901
777,051
331,905
18,421
Operating expenses
Research development
35,490
28,910
24,219
11,580
6,537
Selling general and administrative
135,772
149,992
75,171
30,167
12,312
Total operating expenses
179,208
185,399
101,098
41,747
18,849
Operating income or loss
-80,743
181,502
675,953
290,158
-428
Total other income/expenses net
-
-2,975
-
-
-
Income before tax
-67,454
184,025
677,300
291,684
409
Income tax expense
-17,282
42,102
174,795
72,532
43
Income from continuing operations
-50,172
141,923
506,239
214,310
-411
Net income
-48,682
143,403
507,364
214,310
-411
Net income available to common shareholders
-48,682
143,403
507,364
214,310
-411
Basic EPS
-1.60
4.76
17.25
9.44
-0.02
Diluted EPS
-1.60
4.63
16.38
8.91
-0.02
Basic average shares
29,786
30,097
29,408
22,694
18,709
Diluted average shares
30,189
30,964
30,976
24,056
18,709